WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
WX was delisted on the 10th of December, 2015.
164 hedge funds and large institutions have $2.17B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 76 reducing their positions, and 19 closing their positions.
16% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 19
0% more funds holding
Funds holding: 164 → 164 (0)
5% less capital invested
Capital invested by funds: $2.28B → $2.17B (-$111M)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
29% less call options, than puts
Call options by funds: $856K | Put options by funds: $1.21M
32% less repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 76
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$66.4M |
| 2 |
Mirae Asset Global Investments
Seoul,
South Korea
|
+$45M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$32.3M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$23.8M |
| 5 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$16.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$43.4M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$30.1M |
| 3 |
CCAM
Coupland Cardiff Asset Management
London,
United Kingdom
|
-$29.1M |
| 4 |
BCIM
Black Creek Investment Management
Toronto,
Ontario, Canada
|
-$25.5M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
-$22.8M |
WX Hedge Fund Activity: Q1 2014 in Review
164 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q1 2014, worth a combined $2.17B — down 4.8% from $2.28B a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new WX positions and 19 closed out — a net gain of 3 holders — while 52 added to existing stakes and 76 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $66.4M. The largest seller was Fidelity International, cutting an estimated $43.4M.
- 164 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $2.17B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q1 2014, down 4.8% quarter-over-quarter.
- 22 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q1 2014 and 19 closed out, a net change of +3 holders.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q1 2014 was Acadian Asset Management, an estimated $66.4M added.
- The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q1 2014 was Fidelity International, an estimated $43.4M sold.
Based on aggregated 13F filings for Q1 2014.